Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Inhibiting a protein could enhance effectiveness of cancer immunotherapies

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center discovered inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments.

31 Jul 2018

Researchers discover new antibodies that have capacity to treat all Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

31 Jul 2018

Research may help advance search for more effective drugs to treat Alzheimer's disease

Two new studies published by investigators from Brigham and Women's Hospital illustrate that not all forms of amyloid-beta protein - the protein thought to initiate Alzheimer's disease - play an equally menacing role in the progress of the disease.

31 Jul 2018

Beckman Coulter offers largest range of single color CE-IVD and ASR conjugated antibodies

Beckman Coulter Life Sciences now offers its largest portfolio of single color CE-IVD and ASR (analyte-specific reagent) conjugated antibodies.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Beckman Coulter launches DURA Innovations global flow cytometry business tools

Beckman Coulter Life Sciences expands services by placing DURA Innovations dry reagent solutions at the heart of enhanced external business resources for lab.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter continues to expand portfolio of clinical flow cytometry solutions with its latest innovations.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.

28 Jul 2018

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers - those born between 1945-1965 - are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

27 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

CellMax Life receives six U.S. patents for early cancer detection blood test

CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.

26 Jul 2018

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

Inflammation is part of the body's natural healing process. But when it becomes chronic, inflammation can lead to cancer, Alzheimer's disease and other conditions.

26 Jul 2018

New combination approach may help crush resistance to treatment in lung cancer patients

New-generation lung cancer drugs have been effective in a large number of patients, but within about a year, the patients tend to develop resistance to the therapy.

26 Jul 2018

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Long-lasting control of HIV infection without antiretroviral therapy is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference in Amsterdam.

26 Jul 2018

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Omeros Corporation announced today that the European Medicines Agency's Committee for Orphan Medicinal Products issued a positive opinion recommending orphan drug designation of OMS721 for treatment in hematopoietic stem cell transplantation.

25 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Researchers find that IgM antibody could protect against HIV-1

A team of scientists from Texas Biomedical Research Institute have homed in on an antibody that could protect against infection with HIV-1.

24 Jul 2018

Study reveals protective potential of new class of antibodies against HIV-1 infection

A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus that causes AIDS. Led by Ruth Ruprecht, M.D., Ph.D., the team used an animal model to show for the first time that an antibody called Immunoglobulin M was effective in preventing infection after mucosal AIDS virus exposure.

24 Jul 2018

HCV testing can be successfully implemented in emergency department setting

Boston Medical Center has shown that testing for the Hepatitis C Viru outside the typical high-risk population can be successfully implemented in an emergency department setting, resulting in more patients being screened, diagnosed and treated who might not have been otherwise.

23 Jul 2018

FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system

Parkinson's disease, formerly also referred to as shaking palsy, is one of the most frequent disorders affecting movement and the nervous system.

19 Jul 2018

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.

19 Jul 2018

Antibody News and Research

Further Reading

Inhibiting a protein could enhance effectiveness of cancer immunotherapies

Researchers discover new antibodies that have capacity to treat all Ebola viruses

Research may help advance search for more effective drugs to treat Alzheimer's disease

Beckman Coulter offers largest range of single color CE-IVD and ASR conjugated antibodies

Beckman Coulter launches DURA Innovations global flow cytometry business tools

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Researchers emphasize need for baby boomers to get tested for hepatitis C

CNDA approves KEYTRUDA for treatment of advanced melanoma

CellMax Life receives six U.S. patents for early cancer detection blood test

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

New combination approach may help crush resistance to treatment in lung cancer patients

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Researchers find that IgM antibody could protect against HIV-1

Study reveals protective potential of new class of antibodies against HIV-1 infection

HCV testing can be successfully implemented in emergency department setting

FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system

Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo